Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Gossamer Bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- +2 vs. Q3 2023
- Shares held
- 209.2M
- +3.69M (+1.8%) vs. Q3 2023
- Total value
- $192.0M
- +$20.8M (+12.1%) vs. Q3 2023
- New holders
- 21
- 33 more added
- Sold out
- 19
- 22 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOSS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $60.8M |
| Q1 2026 | 185 | $56.3M |
| Q4 2025 | 195 | $573.4M |
| Q3 2025 | 164 | $473.7M |
| Q2 2025 | 124 | $218.0M |
| Q1 2025 | 119 | $186.9M |
| Q4 2024 | 105 | $155.0M |
| Q3 2024 | 100 | $172.6M |
| Q2 2024 | 94 | $164.7M |
| Q1 2024 | 109 | $233.5M |
| Q4 2023 | 98 | $192.0M |
| Q3 2023 | 96 | $171.2M |
| Q2 2023 | 99 | $74.4M |
| Q1 2023 | 111 | $97.9M |
| Q4 2022 | 120 | $225.1M |
| Q3 2022 | 160 | $1.02B |
| Q2 2022 | 129 | $533.2M |
| Q1 2022 | 141 | $519.8M |
| Q4 2021 | 133 | $664.9M |
| Q3 2021 | 128 | $687.7M |
| Q2 2021 | 115 | $431.1M |
| Q1 2021 | 123 | $501.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Gossamer Bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −3,339,405−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −3,065,136−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −976,108−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −613,028−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −148,270−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −43,583−100.0% | Sold out |
| Change Path, LLC | 0 | $0 | 0.00% | −27,750−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −14,730−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −5,774−100.0% | Sold out |
| Authentikos Wealth Advisory, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −260−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −208−100.0% | Sold out |